1. A Novel Combination of BroadBand Light (BBL® HERO TM ) and Nonablative Fractionated 1,927nm (MOXI TM ) Laser for Addressing Solar Lentigines.
- Author
-
Hennessey E
- Abstract
Solar lentigo is a common condition that can affect people of all ages and ethnicities. The effectiveness of combining laser and light-based modalities for reducing solar lentigines was evaluated. Patients received treatment for facial solar lentigines with an advanced pulsed light device (BBL® HERO
TM ) followed by nonablative fractionated 1,927nm laser (MOXITM ) in a single session. Nonmalignant solar lentigines were evaluated through assessment of photographs and VISIA scans taken before and after treatment. Nine patients aged 29 to 64 years were included in this report. Across all nine patients, there was a significant increase in percentile for brown spots on VISIA scans post-treatment. Follow-up time was variable; in one patient, a marked reduction in hyperpigmentation was observed almost 20 months post-treatment. The results presented in this report demonstrate that combining BBL HERO and MOXI is effective for reducing solar lentigines., Competing Interests: DISCLOSURES: KH is a key opinion leader for Sciton, Inc., and receives honoraria for speaking engagements and for providing clinical education and training to customers., (Copyright © 2024. Matrix Medical Communications. All rights reserved.)- Published
- 2024